Medtronic to Acquire Contego Medical for $380M Plus Potential Additional Payments to Expand Vascular Treatment Portfolio
23 hours ago
1 min read
Galway, Ireland, November 16, 2026 (PR Newswire) -- Medtronic plc (NYSE: MDT) has announced its intent to acquire Contego Medical, Inc., a privately held medical device company specializing in technologies for carotid artery disease and peripheral thrombectomy, in a transaction valued at $380 million, with potential additional payments following the acquisition. The deal builds on Medtronic's existing relationship with Contego, including an exclusive U.S. distribution agreement established in January 2025 and a minority investment dating back to 2020. The acquisition includes Contego's recently FDA-approved Neuroguard IEP Direct System, a transcarotid artery revascularization system with integrated embolic protection and flow reversal, as well as its Excipio thrombectomy devices for treating peripheral vascular disease.
Read full article here.






















Comments